» Articles » PMID: 11020018

Serum Cystatin C As an Endogenous Parameter of the Renal Function in Patients with Normal to Moderately Impaired Kidney Function

Overview
Journal Clin Nephrol
Specialty Nephrology
Date 2000 Oct 6
PMID 11020018
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cystatin C is a proteinase inhibitor with a low molecular weight. The serum levels of cystatin C are mainly dependent on glomerular filtration rate (GFR) making cystatin C an endogenous parameter of GFR. The aim of the study was to elucidate the applicability of serum cystatin C as a parameter of GFR in patients with normal to moderately impaired kidney function and to estimate a reference interval for serum cystatin C.

Patients And Methods: Forty-six patients (25 males and 21 females) aged 22 to 83 years with various kidney diseases and 250 blood donors (164 males and 86 females) aged 19 to 64 years were included. Cystatin C was measured by an automated particle-enhanced nephelometric immunoassay, serum creatinine by an enzymatic and by Jaffé method, urine creatinine by an enzymatic method, and GFR by 99mTc-DTPA clearance.

Results: Serum levels ofcystatin C and creatinine showed increments with decreasing values of 99mTc-DTPA clearance and a linear relationship was found between 99mTc-DTPA clearance and l/serum cystatin C, l/serum creatinine (enzymatic method), and creatinine clearance. Comparison of the non-parametric receiver-operating characteristic (ROC) plots for serum cystatin C (area under the curve (AUC) = 0.996; SE = 0.005), serum creatinine (enzymatic method) (AUC = 0.899; SE = 0.044), serum creatinine (Jaffé method) (AUC = 0.870; SE = 0.051), measured creatinine clearance (AUC = 0.959; SE = 0.025), and estimated creatinine clearance (0.950; SE = 0.029) revealed significant differences for serum cystatin C and serum creatinine (enzymatic and Jaffé method) (p values: 0.03 and 0.01). No significant differences were demonstrated between serum cystatin C and measured and estimated creatinine clearance (p value: 0.14 and 0.12). The non-parametric reference interval for serum cystatin C was calculated to be 0.51-1.02 mg/l (median: 0.79 mg/l; range: 0.33 - 1.07 mg/l).

Conclusion: Serum cystatin C seems to be a better parameter of GFR than serum creatinine in adults with various types of kidney disease with normal to moderately impaired kidney function.

Citing Articles

Markers of Renal Complications in Beta Thalassemia Patients with Iron Overload Receiving Chelation Agent Therapy: A Systematic Review.

Zaky Romadhon P, Ashariati A, Bintoro S, Thaha M, Suryantoro S, Windradi C J Blood Med. 2022; 13:725-738.

PMID: 36467279 PMC: 9717586. DOI: 10.2147/JBM.S387416.


Cystatin C, a Controversial Biomarker in Hypothyroid Patients under Levothyroxine Therapy: THYRenal, a Pilot Cohort Observational Study.

Greco M, Foti D, Aversa A, Fuiano G, Brunetti A, Simeoni M J Clin Med. 2020; 9(9).

PMID: 32933111 PMC: 7565550. DOI: 10.3390/jcm9092958.


Reference intervals for plasma cystatin C and plasma creatinine in adults using methods traceable to international calibrators and reference methods.

Erlandsen E, Randers E J Clin Lab Anal. 2018; 32(6):e22433.

PMID: 29573343 PMC: 6817201. DOI: 10.1002/jcla.22433.


CKD-EPI creatinine-cystatin C glomerular filtration rate estimation equation seems more suitable for Chinese patients with chronic kidney disease than other equations.

Chi X, Li G, Wang Q, Qi Y, Huang K, Zhang Q BMC Nephrol. 2017; 18(1):226.

PMID: 28693441 PMC: 5504640. DOI: 10.1186/s12882-017-0637-z.


The construction of a panel of serum amino acids for the identification of early chronic kidney disease patients.

Li R, Dai J, Kang H J Clin Lab Anal. 2017; 32(3).

PMID: 28643348 PMC: 6817206. DOI: 10.1002/jcla.22282.